Democratic senators urge private insurers fully cover Opill, an OTC contraceptive pill; providers pursue lawsuit against Arizona's abortion rule; a quarter of US medical students contemplate leaving their studies.
Democratic lawmakers have called on the Biden administration to ensure that private health insurance plans provide full coverage for the first OTC birth control pill in the United States, known as Opill, which is set to be available in stores and online early next year, according to CNN. While the FDA approved Opill in July, concerns about its retail price have prompted senators to advocate for comprehensive coverage without the need for a prescription, potentially making this contraceptive option more accessible across the United States and ensuring affordability for women, especially in the wake of the Dobbs decision and the ongoing battle over reproductive health rights.
A US appeals court has rekindled a legal challenge to an Arizona law that prohibits abortions based solely on genetic abnormalities of the fetus, according to Reuters. The 3-judge panel of the 9th US Circuit Court of Appeals unanimously ruled that health care providers can proceed with their lawsuit against the state, overturning a prior decision. Although the panel did not address the law's merits, these rulings grant the providers the right to pursue their challenge in court, who argued that the law's vagueness prevented them from discerning when it applied, resulting in their overcompliance with the statute.
A recent report has revealed that 25% of medical students in the US are contemplating quitting their studies, according to The Hill. Concerns about mental health, study-life balance, and potential clinician shortages, along with the rise of medical misinformation, have driven these students to consider leaving their programs. Overall, the report found that 12% of medical students worldwide were mulling over quitting their studies. Additionally, 58% of medical and nursing students surveyed saw their current studies as stepping stones to careers in health care that do not involve direct patient care. Cost and the overwhelming volume of information were significant factors contributing to their decisions.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen